Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgA1 protease.

Dippica Mistry1, Robert A Stockley

  • 1Respiratory Research Laboratory, Department of Medicine, University of Birmingham, Birmingham B15 2TT, UK. d.v.mistry@bham.ac.uk

The International Journal of Biochemistry & Cell Biology
|November 19, 2005
PubMed
Summary

Pathogenic bacteria use IgA1 proteases to degrade human IgA1, a key defense protein. Inactivating these bacterial proteases may reduce infections and colonization at mucosal surfaces.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.

The European respiratory journal·2025
Same author

Physiological Small Airways Dysfunction and the Bronchodilator Response in Adults With Asthma and Its Risk Factors: A Retrospective Analysis.

Journal of asthma and allergy·2025
Same author

Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiency.

Respiratory medicine·2025
Same author

Proposal and Validation of the Minimum Clinically Important Difference in Emphysema Progression.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2025
Same author

Antitrypsin deficiency: still more to learn about the lung after 60 years.

ERJ open research·2024
Same author

A novel <i>in vitro</i> cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency.

Frontiers in pharmacology·2024

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Immunoglobulin A1 (IgA1) proteases are bacterial enzymes targeting human IgA1.
  • These proteases degrade IgA1 at mucosal sites, weakening host defenses.
  • Pathogenic bacteria utilize IgA1 proteases as virulence factors for colonization.

Purpose of the Study:

  • To investigate the role of IgA1 proteases in bacterial pathogenesis.
  • To explore IgA1 proteases as potential targets for therapeutic intervention.
  • To understand the contribution of iga gene structure to protease function and antigenicity.

Main Methods:

  • Analysis of IgA1 protease gene structure and function.
  • Investigation of IgA1 protease activity on human IgA1 hinge regions.
  • Assessment of IgA1 proteases as virulence factors in bacterial infections.

Main Results:

  • IgA1 proteases cleave specific peptide bonds in the human IgA1 hinge region.
  • Bacterial secretion of IgA1 proteases facilitates evasion of host immune responses.
  • The iga gene structure influences protease antigenicity and cleavage specificity.

Conclusions:

  • IgA1 proteases are significant contributors to bacterial virulence and colonization.
  • Targeting IgA1 proteases offers a potential strategy to combat mucosal infections.
  • Further research into IgA1 protease inactivation could lead to novel therapeutic approaches.

Related Experiment Videos